Increased serum concentrations of cobalamin (vitamin B12) and of the cobalamin binding protein transcobalamin I, an R-binder, are found in at least 6% of patients with cancer. ' Hepatocellular carcinoma tissue has been found to contain 10 times as much cobalamin binding protein as normal liver tissue from the same patient, and it has therefore been suggested that tumour tissue may be the source of the high serum transcobalamin I values found in patients with cancer. 
Discussion
The high concentrations of cobalamin binding protein in the tumour tissues studied suggest that these tissues were the source of the increased binding protein in the serum, although definitive studies of protein synthesis were not undertaken in this case. The strong correlation between cobalamin binding and folate binding protein suggests that the mechanism of production within the tissues was closely related. The possibility of a relation in the synthesis of these proteins is not unexpected. Both cobalamin binding proteins of the R-binder class and folate binding protein have been reported to be present in breast milk,'3 14 plasma, '3 15 and in the secondary granules 
